Bio-Rad Laboratories has unveiled the Bioplex 2200 MMRV IgG kit, which is used to test susceptibility to measles, mumps, rubella and the varicella-zoster virus (chicken pox).
The kit is designed for the Bio-Rad Bioplex 2200 system.
The MMRV IgG kit provides simultaneous results for the four tests that are commonly ordered together to determine a patient's susceptibility to MMRV.
The Bioplex 2200 MMRV IgG kit offers the advantage of multiplexing to deliver test results from a single patient sample.
As a result, laboratories are able to generate test results quickly and with less effort.
MMRV are infectious diseases that are preventable through vaccination.
Maintaining high vaccination coverage and providing MMRV IgG results when an individual's status is uncertain is the most effective ways to prevent disease outbreaks.
Employees in healthcare facilities and military personnel, among others, are typically screened for MMRV IgG to ensure their safety.
The Bioplex 2200 system is an automated, random access multiplex testing system and provides clinical laboratories with the capability to rapidly process or 'multiplex' multiple individual tests that are traditionally processed separately.
Bio-Rad said the Bioplex 2200 system conserves patient sample volume, consolidates workstations, and simplifies workflow.